The proximal tubule contains an autonomous renin-angiotensin system that regulates transport independently of circulating angiotensin II. Androgens are known to increase expression of angiotensinogen, but the effect of androgens on proximal tubule transport is unknown. In this in vivo microperfusion study, we examined the effect of androgens on proximal tubule transport. The volume reabsorptive rate in Sprague-Dawley rats given dihydrotestosterone (DHT) injections was significantly higher than in control rats given vehicle injections (4.57 ± 0.31 vs. 3.31 ± 0.23 nl/mm • min, p < 0.01). Luminally perfusing with either enalaprilat (10 -4 M) to inhibit production of angiotensin II or losartan (10 -8 M), to block the angiotensin receptor decreased the proximal tubule volume reabsorptive rate in DHT treated rats to a significantly greater degree than in control vehicle injected rats. The renal expression of angiotensinogen was shown to be higher in the DHT treated animals using Northern analysis. The expression of angiotensin receptors, determined by specific binding of angiotensin II, was not different in the two groups of animals. Brush border membrane protein abundance of the Na/H exchanger, a membrane transport protein under angiotensin II regulation, was also higher in DHT treated rats vs. control rats. Rats that received DHT had higher blood pressures than the control rats but had no change in their glomerular filtration rate. In addition, serum angiotensin II levels were lower in DHT treated vs. control rats. These results suggest that androgens may directly upregulate the proximal tubule renin-angiotensin system, increase the volume reabsorptive rate, and thereby increase extracellular volume and blood pressure and secondarily decrease serum angiotensin II levels.
INTRODUCTION
The proximal tubule contains an autonomous renin-angiotensin system that can synthesize and luminally secrete angiotensin II or its precursors (4; 5; 29; 34; 36; 40) .
The components of the renin-angiotensin system found within the proximal tubule include angiotensinogen and its mRNA, renin activity, renin mRNA, brush border membrane angiotensin converting enzyme and angiotensin II receptors (6; 7; 11; 12; 20; 40) . Intraluminal angiotensin II is present in proximal tubular fluid at levels 100-fold higher than that found in plasma, thus indicating its robust local production within the proximal tubule (4; 5; 29; 36; 40) .
Using in vivo microperfusion in the hydropenic rat, it has been shown that this intraluminal angiotensin II regulates proximal tubule transport (30) . Luminal perfusion of an angiotensin receptor antagonist (losartan) or of an angiotensin converting enzyme inhibitor (enalaprilat) decreased the rate of proximal tubule volume reabsorption by 35% to 40%, respectively (30) . The decrease in transport observed with luminal enalaprilat is completely reversed with addition of luminal 10 -8 M angiotensin II (27) . These studies are consistent with a role for intraluminal angiotensin II to directly stimulate proximal tubule transport.
Androgens have been found to augment the proximal tubule renin-angiotensin system. Castration of male rats lowers renal angiotensinogen mRNA levels by 60% (15) .
Renal angiotensinogen mRNA levels rise to normal in castrated weanling male rats when given replacement testosterone (15) . In addition, castration of male mice lowers activity of the Na/H exchanger, a brush border membrane transporter regulated by angiotensin II (23) . Subsequent testosterone replacement raises and normalizes Na/H activity levels
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5 (23) . These data indicate that androgens might stimulate the proximal tubule reninangiotensin system and thereby, proximal tubule transport under angiotensin II regulation. However, the effect of androgens on proximal tubule transport remains unknown. The purpose of the present study was to examine the effect of androgens on proximal tubule transport and the role of intraluminal angiotensin II as a mediator of androgen regulation of proximal tubule transport.
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MATERIALS AND METHODS

Preparation of animals:
Male Sprague-Dawley rats weighing between 200 to 250 grams were used for this study. Rat preparation and the in vivo microperfusion described below have been previously described in detail (30; 31) . Briefly, all animals were allowed free access to food and water before anesthesia with intraperitoneal Inactin (100 mg/kg). Rats were placed on a servo-controlled heated table set to maintain body temperature at 37 o C.
The jugular vein was cannulated for infusion of normal saline (0.9% NaCl) at 2.8 ml/hour. A flank incision was used to expose the left kidney, which was then immobilized in a Lucite cup. The kidney was then bathed with water equilibrated light mineral oil heated to 37 o C that was previously bubbled with 95% O2 -5% CO2. The ureter was cannulated with polyethylene tubing (PE-50) to ensure free flow of urine.
Microperfusion experiments commenced 45 minutes after placement of the ureteral cannula.
Sprague Dawley rats injected with dihydrotestosterone (Sigma, St. Louis, MO)
were given intraperitoneal injections at a dose of 50 mg/day for 10 days prior to microperfusion experiments. Dihydrotestosterone (250 mg/cc of corn oil) was dissolved in corn oil using sonication and vortexing prior to intraperitoneal injection. Control rats were injected with corn oil vehicle daily for 10 days prior to microperfusion experiments.
Blood pressure in all rats was measured using a tail cuff (Model 179, IITC, Woodland Hills, CA), where the body of the rat was restrained in an enclosed acrylic tube contained within a lucite box. The temperature within the lucite box was maintained at approximately 30 o C to vasodilate the tail vessels for accurate blood pressure measurement. All animals were initially trained daily for 5 days prior to actual F-00188-2003.R3 7 measurement. All blood pressures are expressed as the systolic blood pressure (SYS BP) and mean arterial pressure in mmHg (MAP). The use of the tail cuff to measure blood pressure is well substantiated and correlates with measurement of systolic and mean arterial blood pressure with an intraarterial catheter (8) .
Glomerular filtration rate determination: Glomerular filtration rate was measured in rats from both the dihydrotestosterone and vehicle injected groups. Briefly, rats were prepared surgically as described above. Rats were subsequently given an intravenous injection of 3 H-inulin (approximately 60 µCi) followed by an infusion of 3 H-inulin in normal saline at a rate of 0.45cc/hr (20 µCi/hr). After a 60 minute period of equilibration, 4 separate 30 minute collections of blood and urine were made and a 100 µl aliquot subsequently placed into scintillation fluid and counted in a scintillation counter (Packard Tri-Carb). The glomerular filtration rate (GFR) was calculated by:
where U is the counts per minute obtained in the urine, V is the urine flow rate in ml/min, and P is the counts per minute obtained in the plasma specimen. GFR was expressed in ml/min.
In vivo microperfusion:
Proximal tubule segments on the surface of the kidney were initially mapped with an injection of a small droplet of oil, and early and late loops were shown to prevent further degradation or generation of angiotensin II within the sample (5) . Plasma samples were extracted on a phenyl-bonded sodium phosphate EDTA column (Bond-Elut; Analytichem, Harbor City, CA). Prior to sample application, the column was prewashed with 3 ml of 90% methanol in water and 6 ml of distilled deionized water. After the sample was applied, the column was then washed with 3 ml of distilled deionized water, followed by 1.5 ml hexane, and finally 1.5 ml chloroform. The angiotensin peptides retained on the column were then eluted with 2 ml of 90% methanol in water, dried under vacuum in a Speed Vac, and subsequently stored at -80 o C until the assay. Measurement of plasma angiotensin II levels prepared as described above has been previously validated and shown to be accurate and correlate with acute and chronic changes in extracellular volume (16; 30).
The angiotensin II assay was performed with an enzyme immunoassay kit (Peninsula Laboratories, Belmont, CA) as previously described in our laboratory (31) .
Briefly, samples and standards were added to microtiter wells containing antibody to angiotensin II bound to the walls of the well. Next, biotinylated "tracer angiotensin II" is added to the well, which competes with angiotensin II in the sample or standard for 
Angiotensinogen message abundance:
Renal cortical mRNA was isolated from control and DHT treated animals using the Messenger RNA Isolation Kit (Stratagene). Briefly, animals were sacrificed, the kidneys were rapidly removed, and the cortex was sliced and quickly put it in 5 ml denaturing solution (containing beta-mercaptoethanol 1:100). Samples were homogenized with Power Gen 125 (Fisher Scientific) homogenizer at 4° C. The lysate was diluted and mixed with 10 ml of elution buffer, then centrifuged (12,000 x g) for 10
minutes. The precipitated proteins were transferred to a tube containing 5 ml oligo(dt) cellulose and incubated for 15 minutes at room temperature with continuous shaking to get complete hybridization. The samples were then centrifuged and washed 3 times with
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12 high-salt washes followed by 2 low-salt washes and finally eluted with three 400-ul aliquots of elution buffer at 68° C. mRNA was then ethanol precipitated and resuspended in elution buffer at 68° C after it was dried under vacuum.
Messenger RNA samples were then denatured and separated on a 1% agaroseformaldehyde gel (3ug/lane) and transferred to GeneScreen Plus hybridization transfer Membrane (NEN, Boston,MA,USA) by capillary method overnight at room temperature.
The samples were then crosslinked in UV stratalinker. Overnight hybridization was done by using ULTRAhyb (Ambion). phosphatase activity was used to determine the enrichment as described previously (27) .
Protein abundance of Na/H exchanger (NHE3) in brush border membrane: BBMV
protein was denatured and separated on a 7.5% polyacrylamide gel as previously 
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RESULTS
Blood pressure and glomerular filtration rate. Blood pressure in rats was obtained via a tail cuff after a 5 day period of training as described above. Systolic blood pressure (SYS BP) and mean arterial pressure (MAP) in DHT treated rats was higher than in control rats (137 ± 4 vs. 124 ± 4 mm Hg, p<0.05 and 104 ± 2 vs. 88 ± 4 mm Hg, p<0.005, respectively) as seen in Figure 1 . The whole animal glomerular filtration rate in DHT injected rats was similar to that in vehicle injected control rats as seen in Figure 2 
Effect of dihydrotestosterone injections on blood dihydrotestosterone, angiotensin II levels, and weight gain. Blood from rats who received either DHT injections or vehicle
injections was assayed for DHT levels. DHT levels were higher in rats that received the DHT injections vs. the corn oil vehicle injections (432.14 ± 104.07 ng/ml vs. 114.63 ± 41.93 ng/ml, p<0.02, n=5 per group) ( Table 1) . Serum angiotensin II levels were also measured in DHT and vehicle injected animals (n=18). As seen in Table 1 treated rats (p=NS; n=8 for control and 9 for DHT treated rats). Again, the decrease in the volume absorption rate was greater in the DHT treated rats than the control rats.
Effect of dihydrotestosterone on mRNA abundance of angiotensinogen in renal tissue.
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To determine the effect of DHT on the intrarenal renin-angiotensin system, renal cortical angiotensinogen was measured using Northern analysis. These results are shown in Figure 4 . Densitometry showed that the angiotensinogen/18S ratio was increased by DHT treatment by two fold (control ratio: 0.18 ± 0.02 vs DHT ratio: 0.41 ± 0.08; p<0.02, n=6 in each group). Thus, DHT treatment increased the expression of angiotensinogen, the substrate for renin and precursor for angiotensin II.
Effect of dihydrotestosterone on protein abundance of Na/H exchanger (NHE3) in brush
border membranes. Protein abundance of the Na/H exchanger (NHE3) was measured in brush border membrane vesicles extracted from kidneys of both DHT injected and control vehicle injected rats using the Western blotting technique. Protein abundance of NHE3 was expressed as the ratio of NHE3 protein to -actin protein (NHE3 / -actin) ( Figure 5 ). As seen in Figure 5 , the amount of NHE3 protein relative to -actin protein within the brush border membrane was higher in kidneys from DHT treated rats than from control rats (1.33 ± 0.11 vs. 0.86 ± 0.11, p< 0.05). These results are consistent with a stimulatory role for androgens to augment expression of NHE3 protein within the brush border membrane.
Effect of dihydrotestosterone on binding of angiotensin II to renal membranes.
To determine whether the effects of DHT on proximal tubule transport could have been mediated by changes in receptors for angiotensin II, binding studies were performed on proximal tubule membranes from control and DHT treated rats. These results are presented in Figure 6 and demonstrate that there was no difference in the specific binding 
DISCUSSION
Hypertension significantly contributes to the development of cardiovascular and renal disease in the United States (14) . The prevalence and incidence of hypertension, in both animal and human studies, is more common in males than in females (1; 14; 17).
Male spontaneously hypertensive (SHR) rats, deoxycorticosterone-salt sensitive and Dahl salt-sensitive rats all have higher blood pressure than their female counterparts (13; 17; 24; 37) . Likewise, in the Framingham study of cardiovascular disease and hypertension in the United States, the prevalence of hypertension in men was higher than in women (33% vs. 27%) (14) . Yet, the etiology of this difference is largely unknown. Animal models of hypertension suggest that androgens may play an important role in the pathogenesis of higher blood pressure in males (32) .
In the SHR rat model of hypertension, castration of male rats at 4 weeks of age attenuates the development of hypertension in adulthood, while testosterone replacement after castration restored hypertension (10) . Male SHR rats given the androgen receptor antagonist, flutamide, also demonstrated lower mean arterial blood pressure, similar to castrated male rats (33) . Ovariectomy had no effect on blood pressure in the female SHR rat (10). However, normotensive female SHR rats become hypertensive when given testosterone treatment as neonates. More recent studies using mice with a Cyp 4a14 gene (arachidonic acid hydroxylase) knockout corroborate the above studies (19) . Mice with the Cyp 4a14 gene knockout are hypertensive, but blood pressures in male mice are higher than female mice (19) . Plasma androgens levels in male Cyp 4a14 knockout mice are two-fold higher than the wild type male counterpart. When male knockout mice were castrated, blood pressure decreased, comparable to the wild type, while Androgens have also been found to affect the activity of the Na/H exchanger, one of the key brush border membrane transporters in the kidney for solute reabsorption (23).
These findings provide support for the possibility that androgens may have a direct effect on proximal tubule transport.
Recently, androgens have been found to alter the metabolism of arachidonic acid in the renal cortex (28) . The authors demonstrated that administration of DHT to rats increased their blood pressure and altered the expression and activity of the renal microsomal CYP450 enzymes (28). The exact mechanism by which CYP450 metabolites of arachidonic acid affects regulation of blood pressure and renal function remains elusive, however, there is abundant data that these metabolites play a role in these processes (35) .
F-00188-2003.R3 The present study demonstrates that dihydrotestosterone augments proximal tubule reabsorption (Figure 3 ). Proximal tubule reabsorption can also rise as a result of a rise in the glomerular filtration rate, a phenomenon known as glomerulotubular balance.
However, the rise in proximal tubule reabsorption in dihydrotestosterone treated animals, occurred without any change in the glomerular filtration rate (Fig. 2) , consistent with a direct tubular effect. Our findings are consistent with those of a previous study in SHR rats, where androgen receptor blockade did not change the glomerular filtration rate (33).
These results are consistent with an effect of androgens on proximal tubule transport independent of changes in the glomerular filtration rate.
To investigate the potential role of intraluminal angiotensin II in the augmentation of volume reabsorption in the dihydrotestosterone treated animal, enalaprilat or losartan was perfused into the lumen of the proximal tubule. As seen in Figure 3 , the decrease in the volume reabsorptive rate after inhibition of luminal angiotensin II production is consistent with a stimulatory role for angiotensin II in proximal tubule transport in the dihydrotestosterone treated animals. Similar results were obtained with the perfusion of losartan in the tubule lumen. The decrease in transport observed with inhibition of angiotensin II production (luminal enalaprilat) was greater in the dihydrotestosterone treated animal than in control animals. This larger decrement in transport suggests that luminal angiotensin II may be responsible for the augmentation in proximal tubule volume reabsorption resulting from androgen administration. This is supported by the fact that the transport rate in the DHT treated animals after the addition of enalaprilat or losartan is identical to that of the control animals after addition of luminal enalaprilat (Fig. 3) .
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24 Androgenic stimulation of the proximal tubule renin-angiotensin system is supported by the finding that whole kidney angiotensinogen mRNA levels fall by over 60% after castration in male WKY rats (15) . Furthermore, when female rats or male rats castrated as weanlings were implanted with testosterone pellets, kidney angiotensinogen mRNA levels rose to levels comparable to normal male rats (15) . In the present study,
we also demonsatrated that administration of DHT to rats increased the expression of angiotensinogen in the renal cortex. An increased level of kidney angiotensinogen mRNA is consistent with increased expression of the renal renin-angiotensin system through an increase in the production of angiotensinogen, a precursor of angiotensin II.
Similar effects of castration and testosterone replacement on renal angiotensinogen mRNA were found in SHR rats (10) .
Androgenic stimulation of the proximal tubule renin-angiotensin system is also supported by our data indicating that brush border membrane protein abundance of the Na/H exchanger, a membrane transport protein under angiotensin II regulation, is higher in DHT treated vs. control animals ( Figure 4 ) (22) . Our findings are corroborated by a previous study where brush border membrane vesicle Na/H exchanger activity is stimulated by the presence of androgens (23) . In these studies, brush border membrane vesicle Na/H exchanger activity was higher in male mice than female mice and castration of male mice decreased exchanger activity, while testosterone replacement increase the rate of exchange by over 100% (23) . The higher Na/H activity after testosterone replacement is consistent with our results indicating greater Na/H protein abundance in the brush border membrane of the DHT treated animals ( Figure 4 ).
25 Na/H activity is known to be under regulation by angiotensin II (3; 22) .
Administration of luminal angiotensin II has been shown to augment bicarbonate transport in the in vitro microperfused rabbit proximal tubule (3). The rise in transport was inhibited with luminal losartan, an angiotensin II receptor antagonist (3) . Given that the Na/H exchanger under regulation by androgens and angiotensin II, it is intriguing to consider that androgens may regulate the Na/H exchanger via modulation of the proximal tubule renin-angiotensin system.
In contrast to androgenic stimulation of the proximal tubule renin-angiotensin system, the systemic renin-angiotensin system may be suppressed. As seen in Table 1 , the serum angiotensin II levels in the DHT treated animals were lower than that found in the control animals. It is conceivable that the increased proximal tubule volume reabsorption would increase extracellular volume and suppress systemic angiotensin II levels. A rise in extracellular volume in the DHT treated animals would be consistent with three of our findings, including hypertension, increased weight gain, and lower serum angiotensin II levels. Weight gain over the 10 day period of dihydrotestosterone/vehicle injections was two-fold higher in the androgen treated animals (75 ± 13 vs. 37 ± 12 gm, p<0.05) and mean blood pressure in androgen treated animals was nearly 18% higher as shown in Figure 1 (104 ± 2 vs. 88 ± 4 mm Hg, p<0.005). Androgens may augment proximal tubule volume reabsorption via the proximal tubule renin-angiotensin system and raise extracellular volume and blood pressure.
In summary, we demonstrate that DHT administration in rats increases weight gain, blood pressure, proximal tubule volume reabsorption, and lowers serum angiotensin Luminal enalaprilat decreased the volume reabsorptive rate in both control vehicle rats ( * p < 0.05 vs. control perfusate) and DHT rats (+ p < 0.001 vs. control perfusate), but the decrement in the DHT rats was greater than in control (p < 0.05). Similar results were obtained using luminal losartan Control DHT
